Delivery Order SPE2DB25D3201-SPE2DB25FNVBD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count) valued at $1,128.63. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,135.88. This non-competitive set-aside delivery order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete purchase order issued under a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,313.95 to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units). This firm fixed-price delivery order, awarded on July 18, 2025, was completed by July 21, 2025, with no set-aside designation applied. The award utilizes a competitive procurement process, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. Performance of this...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
- This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,193.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Isoniazid 300 mg tablets in quantities of 30. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $60,131.30 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,858.54 from the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of July 31, 2025. The work will be performed at the contractor's Corporate Office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $6,139.94 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVBDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Isosorbide Mononitrate 120 mg tablets (100-count unit) with a ceiling value of $1,384.36. This is a firm fixed-price delivery order executed under a non-competitive set-aside arrangement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The place of performance is located at the company's corporate office in Conshohocken, PA 19428. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. The pharmaceutical supply supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contract mechanism designed to meet ongoing federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/23/25 |